Entera Bio director reports no owned securities

Entera Bio Ltd. director Germano Geno J filed an initial Form 3 reporting no securities beneficially owned in the company.

Rhea-AI Filing Summary

Entera Bio Ltd. director Germano Geno J filed an initial Form 3 reporting no securities beneficially owned in the company. The filing identifies him as a director, with the event date listed as 02/04/2026 and the statement signed by an attorney-in-fact.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Entera Bio (ENTX) Form 3 filed by Germano Geno J report?

The Form 3 for Entera Bio Ltd. reports that director Germano Geno J currently has no securities beneficially owned in the company. It is an initial ownership statement filed pursuant to federal securities law disclosure requirements for insiders.

What is the event date on the Entera Bio (ENTX) Form 3 for Germano Geno J?

The event date on the Form 3 for Entera Bio Ltd. is 02/04/2026. This date reflects when the circumstances requiring the ownership report occurred, such as the point at which the individual became a reportable insider under the applicable securities rules.

What insider role does Germano Geno J have at Entera Bio (ENTX) according to the Form 3?

The Form 3 identifies Germano Geno J as a director of Entera Bio Ltd. No officer role, 10% ownership, or other relationship boxes are marked, indicating his reportable status is specifically tied to serving on the company’s board of directors.

Does the Entera Bio (ENTX) Form 3 show any derivative or non-derivative holdings for Germano Geno J?

No, the filing states that no securities are beneficially owned by Germano Geno J. Both the non-derivative and derivative ownership tables contain no positions, and the explanation of responses confirms the absence of any beneficial holdings in Entera Bio Ltd.

Who signed the Entera Bio (ENTX) Form 3 on behalf of Germano Geno J and when?

The Form 3 is signed "/s/ Dana Yaacov-Garbeli, attorney-in-fact" dated 02/09/2026. This indicates an authorized representative signed the ownership report for the reporting person under a power of attorney arrangement recognized in the filing’s signature block.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 08:50 AM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Germano Geno J

(Last) (First) (Middle)

KIRYAT HADASSAH

MINRAV BUILDING, 5TH FLOOR

(Street)

JERUSALEM L3 9112002

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2026

3. Issuer Name and Ticker or Trading Symbol
Entera Bio Ltd. [ ENTX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Dana Yaacov-Garbeli, Attorney-in-fact	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.